Organovo Historical Balance Sheet

ONVO Stock

USD 0.48 0.04 9.09%

Trend analysis of Organovo Holdings balance sheet accounts such as Accounts Payable of 595.8 K provides information on Organovo Holdings' total assets, liabilities, and equity, which is the actual value of Organovo Holdings to its prevalent stockholders. By breaking down trends over time using Organovo Holdings balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Organovo Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Organovo Holdings is a good buy for the upcoming year.

Organovo Holdings Inventory

239,418

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organovo Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Organovo Stock, please use our How to Invest in Organovo Holdings guide.

About Organovo Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Organovo Holdings at a specified time, usually calculated after every quarter, six months, or one year. Organovo Holdings Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Organovo Holdings and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Organovo currently owns. An asset can also be divided into two categories, current and non-current.

Organovo Holdings Balance Sheet Chart

At this time, Organovo Holdings' Other Assets are very stable compared to the past year. As of the 1st of December 2024, Capital Lease Obligations is likely to grow to about 1.5 M, while Total Assets are likely to drop about 6 M.

Total Assets Total Current Liabilities Accounts Payable Cash And Short Term Investments

Add Fundamental

Total Assets

Total assets refers to the total amount of Organovo Holdings assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Organovo Holdings books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Organovo Holdings balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Organovo Holdings are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents Organovo Holdings obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Organovo Holdings are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Organovo Holdings balance sheet. This account contains Organovo Holdings investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Organovo Holdings fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Most accounts from Organovo Holdings' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Organovo Holdings current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organovo Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Organovo Stock, please use our How to Invest in Organovo Holdings guide.At this time, Organovo Holdings' Other Assets are very stable compared to the past year. As of the 1st of December 2024, Capital Lease Obligations is likely to grow to about 1.5 M, while Total Assets are likely to drop about 6 M.

	2021	2022	2023	2024 (projected)
Total Current Liabilities	1.4M	3.7M	1.9M	3.3M
Total Assets	33.3M	20.3M	6.3M	6.0M

Total Current Liabilities Total Assets

Organovo Holdings balance sheet Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Long Term Debt Total	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Non Current Liabilities Total	Inventory	Property Plant And Equipment Gross	Other Current Liab	Property Plant And Equipment Net	Current Deferred Revenue	Other Assets
Total Assets		0.07	0.97	-1.0	-0.09	0.63	1.0	1.0	0.6	-0.12	0.55	0.33	0.09	1.0	0.69	0.34	0.55	0.01	0.48	0.14	0.2	0.39	-0.51	0.53	-0.33	-0.26
Total Current Liabilities	0.07		-0.16	-0.07	0.24	0.19	0.06	0.06	0.18	-0.44	-0.11	-0.26	0.99	0.07	0.23	-0.32	0.0	-0.22	0.15	-0.19	0.27	-0.01	0.35	0.02	0.26	-0.32
Total Stockholder Equity	0.97	-0.16		-0.97	-0.13	0.58	0.97	0.97	0.56	-0.04	0.56	0.37	-0.14	0.97	0.64	0.39	0.53	0.05	0.44	0.16	0.13	0.37	-0.58	0.51	-0.39	-0.19
Net Debt	-1.0	-0.07	-0.97		0.02	-0.61	-1.0	-1.0	-0.63	0.19	-0.51	-0.27	-0.08	-1.0	-0.71	-0.29	-0.47	0.03	-0.46	-0.06	-0.18	-0.3	0.47	-0.46	0.33	0.29
Retained Earnings	-0.09	0.24	-0.13	0.02		-0.23	-0.05	-0.05	0.14	-0.89	-0.67	-0.96	0.18	-0.06	0.0	-0.66	-0.5	-0.63	0.03	-0.75	0.15	-0.54	0.81	-0.31	0.33	-0.75
Accounts Payable	0.63	0.19	0.58	-0.61	-0.23		0.62	0.62	0.48	0.0	0.31	0.33	0.2	0.62	0.57	0.09	0.47	-0.18	0.29	0.14	0.09	0.44	-0.48	0.5	-0.33	-0.08
Cash	1.0	0.06	0.97	-1.0	-0.05	0.62		1.0	0.62	-0.16	0.53	0.29	0.07	1.0	0.7	0.3	0.49	-0.01	0.46	0.08	0.17	0.33	-0.49	0.48	-0.34	-0.27
Cash And Short Term Investments	1.0	0.06	0.97	-1.0	-0.05	0.62	1.0		0.62	-0.16	0.53	0.29	0.07	1.0	0.7	0.31	0.5	-0.01	0.46	0.09	0.17	0.33	-0.49	0.48	-0.34	-0.27
Common Stock Total Equity	0.6	0.18	0.56	-0.63	0.14	0.48	0.62	0.62		-0.38	-0.02	0.02	0.16	0.62	0.95	0.19	-0.01	-0.58	0.63	-0.16	0.43	-0.05	-0.12	0.1	-0.12	-0.41
Common Stock Shares Outstanding	-0.12	-0.44	-0.04	0.19	-0.89	0.0	-0.16	-0.16	-0.38		0.49	0.85	-0.37	-0.15	-0.28	0.61	0.43	0.69	-0.21	0.81	-0.31	0.53	-0.65	0.25	-0.25	0.77
Other Current Assets	0.55	-0.11	0.56	-0.51	-0.67	0.31	0.53	0.53	-0.02	0.49		0.75	-0.07	0.53	0.13	0.53	0.51	0.77	0.03	0.45	-0.2	0.35	-0.74	0.28	-0.45	0.51
Other Stockholder Equity	0.33	-0.26	0.37	-0.27	-0.96	0.33	0.29	0.29	0.02	0.85	0.75		-0.2	0.3	0.17	0.75	0.58	0.62	0.09	0.75	-0.12	0.59	-0.88	0.39	-0.4	0.65
Total Liab	0.09	0.99	-0.14	-0.08	0.18	0.2	0.07	0.07	0.16	-0.37	-0.07	-0.2		0.08	0.22	-0.26	0.09	-0.18	0.16	-0.1	0.27	0.08	0.31	0.1	0.26	-0.29
Total Current Assets	1.0	0.07	0.97	-1.0	-0.06	0.62	1.0	1.0	0.62	-0.15	0.53	0.3	0.08		0.71	0.32	0.51	-0.01	0.48	0.09	0.19	0.34	-0.49	0.49	-0.34	-0.27
Common Stock	0.69	0.23	0.64	-0.71	0.0	0.57	0.7	0.7	0.95	-0.28	0.13	0.17	0.22	0.71		0.25	0.1	-0.48	0.62	-0.06	0.4	0.05	-0.28	0.17	-0.22	-0.33
Short Long Term Debt Total	0.34	-0.32	0.39	-0.29	-0.66	0.09	0.3	0.31	0.19	0.61	0.53	0.75	-0.26	0.32	0.25		0.51	0.43	0.34	0.7	0.19	0.46	-0.53	0.41	0.12	0.43
Non Current Assets Total	0.55	0.0	0.53	-0.47	-0.5	0.47	0.49	0.5	-0.01	0.43	0.51	0.58	0.09	0.51	0.1	0.51		0.36	0.35	0.71	0.25	0.95	-0.57	0.96	-0.04	0.02
Non Currrent Assets Other	0.01	-0.22	0.05	0.03	-0.63	-0.18	-0.01	-0.01	-0.58	0.69	0.77	0.62	-0.18	-0.01	-0.48	0.43	0.36		-0.33	0.51	-0.42	0.27	-0.45	0.1	-0.2	0.69
Net Receivables	0.48	0.15	0.44	-0.46	0.03	0.29	0.46	0.46	0.63	-0.21	0.03	0.09	0.16	0.48	0.62	0.34	0.35	-0.33		-0.01	0.86	0.27	-0.01	0.46	0.08	-0.51
Non Current Liabilities Total	0.14	-0.19	0.16	-0.06	-0.75	0.14	0.08	0.09	-0.16	0.81	0.45	0.75	-0.1	0.09	-0.06	0.7	0.71	0.51	-0.01		-0.12	0.8	-0.59	0.61	-0.03	0.51
Inventory	0.2	0.27	0.13	-0.18	0.15	0.09	0.17	0.17	0.43	-0.31	-0.2	-0.12	0.27	0.19	0.4	0.19	0.25	-0.42	0.86	-0.12		0.19	0.21	0.4	0.38	-0.57
Property Plant And Equipment Gross	0.39	-0.01	0.37	-0.3	-0.54	0.44	0.33	0.33	-0.05	0.53	0.35	0.59	0.08	0.34	0.05	0.46	0.95	0.27	0.27	0.8	0.19		-0.55	0.93	-0.05	0.07
Other Current Liab	-0.51	0.35	-0.58	0.47	0.81	-0.48	-0.49	-0.49	-0.12	-0.65	-0.74	-0.88	0.31	-0.49	-0.28	-0.53	-0.57	-0.45	-0.01	-0.59	0.21	-0.55		-0.42	0.58	-0.5
Property Plant And Equipment Net	0.53	0.02	0.51	-0.46	-0.31	0.5	0.48	0.48	0.1	0.25	0.28	0.39	0.1	0.49	0.17	0.41	0.96	0.1	0.46	0.61	0.4	0.93	-0.42		0.07	-0.19
Current Deferred Revenue	-0.33	0.26	-0.39	0.33	0.33	-0.33	-0.34	-0.34	-0.12	-0.25	-0.45	-0.4	0.26	-0.34	-0.22	0.12	-0.04	-0.2	0.08	-0.03	0.38	-0.05	0.58	0.07		-0.2
Other Assets	-0.26	-0.32	-0.19	0.29	-0.75	-0.08	-0.27	-0.27	-0.41	0.77	0.51	0.65	-0.29	-0.27	-0.33	0.43	0.02	0.69	-0.51	0.51	-0.57	0.07	-0.5	-0.19	-0.2

Click cells to compare fundamentals

Organovo Holdings Account Relationship Matchups

Organovo Holdings balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	28.4M	39.9M	33.3M	20.3M	6.3M	6.0M
Total Current Liabilities	1.8M	721K	1.4M	3.7M	1.9M	3.3M
Total Stockholder Equity	26.6M	39.2M	30.2M	15.3M	3.6M	3.4M
Net Debt	(27.4M)	(37.4M)	(26.5M)	(13.5M)	(1.5M)	(1.6M)
Retained Earnings	(279.5M)	(296.3M)	(307.7M)	(325.0M)	(339.7M)	(322.7M)
Accounts Payable	720K	281K	415K	331K	627K	595.8K
Cash	27.4M	37.4M	28.7M	15.3M	2.9M	2.8M
Cash And Short Term Investments	27.4M	37.4M	28.7M	16.0M	2.9M	2.8M
Common Stock Total Equity	111K	124K	131K	9K	10.4K	9.8K
Common Stock Shares Outstanding	6.5M	6.9M	8.7M	8.7M	9.1M	6.1M
Liabilities And Stockholders Equity	28.4M	39.9M	33.3M	20.3M	6.3M	6.0M
Other Current Assets	851K	2.1M	1.7M	889K	705K	1.0M
Other Stockholder Equity	306.0M	335.5M	337.9M	340.3M	343.3M	242.2M
Total Liab	1.8M	721K	3.1M	5.0M	2.7M	3.7M
Total Current Assets	28.3M	38.4M	29.5M	17.0M	3.9M	3.7M
Common Stock	111K	124K	131K	9K	10K	9.5K
Non Current Assets Total	123K	1.5M	3.8M	3.3M	2.4M	2.4M
Non Currrent Assets Other	123K	1.1M	948K	658K	437K	413.2K
Net Receivables	558K	111K	0.0	152K	33K	31.4K
Non Current Liabilities Total	720K	281K	1.7M	1.3M	888K	664.9K
Property Plant And Equipment Gross	415K	381K	3.9M	3.9M	3.2M	2.4M
Other Current Liab	1.1M	440K	10K	2.4M	221K	210.0K
Property Plant And Equipment Net	0.0	381K	2.8M	2.6M	2.0M	2.2M
Intangible Assets	123K	109K	94K	13K	8K	7.6K
Net Tangible Assets	26.6M	39.1M	30.1M	15.3M	13.8M	13.1M
Net Invested Capital	26.6M	39.2M	30.2M	15.3M	3.6M	3.4M
Net Working Capital	26.5M	37.7M	28.2M	13.4M	2.1M	2.0M

Pair Trading with Organovo Holdings

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Organovo Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organovo Holdings will appreciate offsetting losses from the drop in the long position's value.

Moving against Organovo Stock

0.81	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.79	GILD	Gilead Sciences	Pair Corr
0.78	EWTX	Edgewise Therapeutics	Pair Corr
0.77	BHC	Bausch Health Companies	Pair Corr
0.67	ESPR	Esperion Therapeutics Buyout Trend	Pair Corr

The ability to find closely correlated positions to Organovo Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Organovo Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Organovo Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Organovo Holdings to buy it.

The correlation of Organovo Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Organovo Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Organovo Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Organovo Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Organovo Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organovo Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organovo Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organovo Holdings Stock:

How To Invest In Organovo

Details

Is Organovo Stock a good investment?

Details

What is Organovo Holdings' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

To learn how to invest in Organovo Stock, please use our How to Invest in Organovo Holdings guide.

You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organovo Holdings. If investors know Organovo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organovo Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.04)

Revenue Per Share

0.008

Quarterly Revenue Growth

(0.48)

Return On Assets

(0.89)

Return On Equity

(2.07)

The market value of Organovo Holdings is measured differently than its book value, which is the value of Organovo that is recorded on the company's balance sheet. Investors also form their own opinion of Organovo Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organovo Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organovo Holdings' market value can be influenced by many factors that don't directly affect Organovo Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Organovo Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organovo Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organovo Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Organovo Historical Balance Sheet

Organovo Holdings Inventory

239,418

About Organovo Balance Sheet Analysis

Organovo Holdings Balance Sheet Chart

Total Assets

Total Current Liabilities

Accounts Payable

Cash And Short Term Investments

Organovo Holdings balance sheet Correlations

Organovo Holdings Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Organovo Holdings balance sheet Accounts

Pair Trading with Organovo Holdings

Moving against Organovo Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments

Total Current Assets	- 1.0	Net Debt
Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Net Debt	- 1.0	Total Assets
Net Debt	- 0.97	Total Stockholder Equity
Other Stockholder Equity	- 0.96	Retained Earnings